Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug tested for mysterious, debilitating itch

NCT ID NCT07074977

Recruiting now Symptom relief Sponsor: Galderma R&D Source: ClinicalTrials.gov ↗

Summary

This study is testing an injectable drug called nemolizumab in adults with severe, long-term itching that has no clear cause. The main goal is to understand how the drug moves through the body and how it relates to reducing itch intensity. About 50 participants will receive either the drug or a placebo for 16 weeks to see how well it works and how safe it is.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PRURITUS OF UNKNOWN ORIGIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Galderma Investigational Site (#8212)

    NOT_YET_RECRUITING

    Portland, Oregon, 97210, United States

  • Galderma Investigational Site (#8255)

    NOT_YET_RECRUITING

    Philadelphia, Pennsylvania, 19103, United States

  • Galderma Investigational Site (#8295)

    NOT_YET_RECRUITING

    Miami, Florida, 33136, United States

  • Galderma Investigational Site (#9975)

    NOT_YET_RECRUITING

    Sacramento, California, 95815, United States

  • Galderma Investigational Site (site# 7054)

    RECRUITING

    Tampa, Florida, 33609, United States

  • Galderma Investigational Site (site# 7075)

    RECRUITING

    San Francisco, California, 94115, United States

  • Galderma Investigational Site (site# 7110)

    RECRUITING

    New City, New York, 10956, United States

  • Galderma Investigational Site (site# 7111)

    RECRUITING

    Fargo, North Dakota, 58103, United States

  • Galderma Investigational Site (site# 8003)

    NOT_YET_RECRUITING

    Webster, Texas, 77598, United States

  • Galderma Investigational Site (site# 8021)

    NOT_YET_RECRUITING

    San Diego, California, 92123, United States

  • Galderma Investigational Site (site# 8108)

    NOT_YET_RECRUITING

    Las Vegas, Nevada, 89145, United States

  • Galderma Investigational Site (site# 8130)

    NOT_YET_RECRUITING

    Los Angeles, California, 90045, United States

  • Galderma Investigational Site (site# 8142)

    NOT_YET_RECRUITING

    Indianapolis, Indiana, 46250, United States

  • Galderma Investigational Site (site# 8521)

    NOT_YET_RECRUITING

    Saint Joseph, Missouri, 64506, United States

  • Galderma Investigational Site (site# 8725)

    RECRUITING

    Morgantown, West Virginia, 26505, United States

  • Galderma Investigational Site (site# 8743)

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Galderma Investigational Site (site# 8862)

    NOT_YET_RECRUITING

    Fairfax, Virginia, 22031, United States

  • Galderma Investigational Site (site# 8893)

    RECRUITING

    Birmingham, Alabama, 35244, United States

Conditions

Explore the condition pages connected to this study.

CHRONIC PRURITUS OF UNKNOWN ORIGIN